Muhammad M. Khan, Ph.D. - Publications
Affiliations: | 2010 | Education | University of Massachusetts, Amherst, Amherst, MA |
Area:
ChemoreceptionYear | Citation | Score | |||
---|---|---|---|---|---|
2003 | Evans DR, Parikh VV, Khan MM, Coussons C, Buckley PF, Mahadik SP. Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 69: 393-9. PMID 14623492 DOI: 10.1016/j.plefa.2003.08.010 | 0.347 | |||
2003 | Parikh V, Evans DR, Khan MM, Mahadik SP. Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome. Schizophrenia Research. 60: 117-23. PMID 12591576 DOI: 10.1016/S0920-9964(02)00434-6 | 0.351 | |||
2002 | Mahadik SP, Khan MM, Evans DR, Parikh VV. Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome. Schizophrenia Research. 58: 55-62. PMID 12363390 DOI: 10.1016/S0920-9964(01)00378-4 | 0.369 | |||
2002 | Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh VV, Mahadik SP. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophrenia Research. 58: 1-10. PMID 12363384 DOI: 10.1016/S0920-9964(01)00334-6 | 0.372 | |||
Show low-probability matches. |